KKR Genetic Disorder L.P.
CIK 1780408 · last filed 2025-03-07
KKR Genetic Disorder L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for BBIO, was dated May 12, 2025. Across all open-market trades the lifetime net is −$1.78B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.65B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.65B
1
4
-$1.78B
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | 10%+ Owner | 19,260,971 | $85.55 | $1.65B | -$1.78B | 1 | 2025-03-07 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-12 | BBIO | Notice (144) | −6,000,000 | -$214.08M | EDGAR |
| 2025-03-07 | BBIO | Sell (S) | −54,000,000 | -$1.78B | EDGAR |
| 2025-03-05 | BBIO | Notice (144) | −6,000,000 | -$209.82M | EDGAR |
| 2024-09-13 | BBIO | Notice (144) | −5,800,000 | -$156.31M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.